ProCE Banner Activity

Whom to Screen for Hepatitis Delta Virus

Podcast Episodes

Listen as 2 experts discuss the impact of hepatitis delta virus infection on liver disease progression and the potential burden of going undiagnosed.

Released: December 15, 2022

Expiration: December 14, 2023

No longer available for credit.

Share

Faculty

Nancy Reau

Nancy Reau, MD

Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center 
Chicago, Illinois

Coleman I. Smith

Coleman I. Smith, MD

Professor of Medicine
Hepatologist
Georgetown Transplant Institute
Georgetown University
Washington, DC

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Gilead Sciences, Inc.

Partners

AHF

ProCE Banner

Faculty Disclosure

Primary Author

Nancy Reau, MD

Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center 
Chicago, Illinois

Nancy Reau, MD: consultant/advisor/speaker: AbbVie, Antios, Arbutus, Gilead, Intercept, Salix; research support: AbbVie, Gilead, Intercept.

Coleman I. Smith, MD

Professor of Medicine
Hepatologist
Georgetown Transplant Institute
Georgetown University
Washington, DC

Coleman I. Smith, MD: researcher: AbbVie, Genfit, Gilead Sciences.